Dyronib 70 mg Tablet
$215,31
$51,78
Dyronib 70 mg Tablet is a targeted therapy that features dasatinib as its active component, primarily designed to combat specific forms of cancer, notably chronic myeloid leukemia (CML), a malignancy that disrupts normal white blood cell production. By inhibiting certain proteins involved in the growth and spread of cancer cells, Dyronib effectively helps in managing and potentially reversing the progression of this blood cancer. Patients taking this medication should be aware of potential side effects, which can include low blood cell counts, fluid retention, and elevated liver enzymes, necessitating regular monitoring by healthcare providers. It is essential to follow your doctor’s guidelines closely to minimize risks and maximize therapeutic benefits. While Dyronib 70 mg can offer significant advantages for those diagnosed with CML, it is not suitable for everyone, particularly individuals with certain pre-existing conditions or those who are pregnant or breastfeeding. Always discuss your complete medical history with your physician to ensure this treatment aligns with your health needs. By understanding how Dyronib works and adhering to medical advice, patients can take proactive steps toward managing their condition effectively.
數量
Active Pharmaceutical Ingredient
Uses
• Dyronib 70 mg tablet is primarily utilized in the treatment of chronic myeloid leukemia (CML), a cancer that impacts the blood and bone marrow. Patients with CML may experience symptoms such as fatigue, weakness, and an enlarged spleen. By targeting specific pathways involved in the disease, Dyronib 70 mg tablet helps manage these symptoms effectively. This targeted approach can lead to improved quality of life for individuals diagnosed with CML.
• Another significant application of Dyronib 70 mg tablet is in the management of acute lymphoblastic leukemia (ALL). This aggressive form of leukemia affects the white blood cells and often presents with symptoms such as shortness of breath and easy bruising. Dyronib 70 mg tablet works by interfering with the growth and spread of cancer cells in the bone marrow. As a result, it can help alleviate some of the debilitating effects associated with ALL.
• Dyronib 70 mg tablet is also indicated for patients who have experienced a relapse or have resistance to other treatments for leukemia. In such cases, this medication provides an alternative therapeutic option. By utilizing Dyronib 70 mg tablet, healthcare providers can offer a new line of defense against the disease. This is particularly important for patients who may not have responded well to conventional therapies.
• In certain clinical scenarios, Dyronib 70 mg tablet may be used in combination with other therapies to enhance treatment outcomes. This combination approach can be beneficial for patients with complex cases of leukemia. Dyronib 70 mg tablet complements other treatments, targeting the cancer more effectively. This strategy aims to optimize patient response and improve overall prognosis in leukemia management.
Benefits
Dyronib 70 mg Tablet is effective and has a high rate of response in people with chronic myeloid leukemia (CML) and acute lymphoblastic leukemia. It decreases the number of cancer cells in the blood and bone marrow and improves blood counts in people with CML or ALL. Dyronib Tablet is usually taken once a day, which may be more convenient for some people compared to other treatments. Anti-cancer Drug Dyronib is effective in people with CML or ALL who have not responded to other treatments.
Side Effects
Dyronib 70 mg Tablet may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Fever
• Nausea
• Vomiting
• Bleeding
• Skin rash
• Diarrhoea
• Infection
• Bone marrow suppression
• Pleural effusion
• Abdominal pain
Common Side Effects
• Difficulty breathing
• Headache
• Tiredness
• Fatigue
• Muscle and joint pain
• Swelling in the hands and feet
How To Use
Dyronib 70 mg Tablet Pack may be taken with or without food. Take it at the same time each day. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Dasatinib Tablet 70 mg. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Patients with kidney disease should closely monitor kidney function while taking Dasatinib Tablet 70 mg and report any unusual symptoms or changes in kidney function to their physician. The dose of Anti-cancer Drug Dyronib should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Dyronib 70 mg. Dyronib 70 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Dasatinib Tablet 70 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Dasatinib Tablet 70 mg should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Dyronib 70 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Dyronib 70 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Dyronib Tablet may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Dyronib 70 mg Tablet Pack during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Dyronib 70 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Dyronib 70 mg.